Anu Laboratories IPO which closed for subscription last week has fared very well. Considering the volatility in the secondary markets, the IPO still managed to get oversubscribed by over 8 times. Retail investors who applied for the maximum under the retail investors category will get firm allotment. Though retail investors have shown full confidence in this IPO, QIB’s have by and large remained on the sidelines. It will be interesting to have a look at the listing gains that this IPO offers on listing.